Announced Fri, 11 Sept · 19:29 IST
Sandu Pharma 41st AGM held; resolutions on dividend, auditor change, MD redesignation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹37.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.5+0.3+0.0+1.3——————
Up moveDown movePending
AI summary
Sandu Pharma held its 41st AGM on 11 Sep 2026 via video conferencing. Key resolutions: adoption of FY26 financials, dividend declaration, reappointment of Jayshree Sandu, appointment of new statutory auditors M/s Dave and Dave for 5 years, related party transactions with Sandu Brothers, redesignation of Balram Viswanathan as CMD, and appointment of Neeti Madan Kapre as Independent Director. Results due within 48 hours.
Likely market impact
Dividend, new statutory auditors for 5 years, and CMD redesignation are key items. Await voting results for confirmation.